1.42
+0.07(+5.19%)
Currency In USD
| Previous Close | 1.35 |
| Open | 1.36 |
| Day High | 1.42 |
| Day Low | 1.36 |
| 52-Week High | 2.04 |
| 52-Week Low | 1.11 |
| Volume | 2.45M |
| Average Volume | 2.81M |
| Market Cap | 1.13B |
| PE | -5.46 |
| EPS | -0.26 |
| Moving Average 50 Days | 1.35 |
| Moving Average 200 Days | 1.48 |
| Change | 0.07 |
If you invested $1000 in OPKO Health, Inc. (OPK) 10 years ago, it would be worth $137.73 as of September 09, 2025 at a share price of $1.42. Whereas If you bought $1000 worth of OPKO Health, Inc. (OPK) shares 5 years ago, it would be worth $455.13 as of September 09, 2025 at a share price of $1.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OPKO Health to Report Second Quarter 2025 Financial Results on July 31
GlobeNewswire Inc.
Jul 24, 2025 8:05 PM GMT
MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
GlobeNewswire Inc.
Jul 08, 2025 12:00 PM GMT
MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrom
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
GlobeNewswire Inc.
Jun 25, 2025 3:00 PM GMT
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discu